Tasneem S[au] - Search Results

Year	Number of Results
2001	3
2005	1
2007	4
2008	3
2009	2
2010	1
2011	4
2012	5
2014	2
2015	4
2016	4
2017	7
2018	7
2019	9
2020	8
2021	7
2022	6
2023	16
2024	15

1

Molecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents.

Tasneem S, Liu B, Li B, Choudhary MI, Wang W. Tasneem S, et al. Pharmacol Res. 2019 Jan;139:126-140. doi: 10.1016/j.phrs.2018.11.001. Epub 2018 Nov 3. Pharmacol Res. 2019. PMID: 30395947 Review.

2

Multimerin 1.

Jeimy SB, Tasneem S, Cramer EM, Hayward CP. Jeimy SB, et al. Among authors: tasneem s. Platelets. 2008 Mar;19(2):83-95. doi: 10.1080/09537100701832157. Platelets. 2008. PMID: 18297547 Review.

3

Green recipes to quinoline: A review.

Nainwal LM, Tasneem S, Akhtar W, Verma G, Khan MF, Parvez S, Shaquiquzzaman M, Akhter M, Alam MM. Nainwal LM, et al. Among authors: tasneem s. Eur J Med Chem. 2019 Feb 15;164:121-170. doi: 10.1016/j.ejmech.2018.11.026. Epub 2018 Dec 21. Eur J Med Chem. 2019. PMID: 30594028 Review.

4

Rare inherited coagulation and fibrinolytic defects that challenge diagnostic laboratories.

Mathews N, Tasneem S, Hayward CPM. Mathews N, et al. Among authors: tasneem s. Int J Lab Hematol. 2023 Jun;45 Suppl 2:30-43. doi: 10.1111/ijlh.14084. Epub 2023 May 21. Int J Lab Hematol. 2023. PMID: 37211424 Review.

5

Screening and diagnosis of inherited platelet disorders.

Bourguignon A, Tasneem S, Hayward CP. Bourguignon A, et al. Among authors: tasneem s. Crit Rev Clin Lab Sci. 2022 Sep;59(6):405-444. doi: 10.1080/10408363.2022.2049199. Epub 2022 Mar 28. Crit Rev Clin Lab Sci. 2022. PMID: 35341454 Review.

6

Heterocyclic Moieties as HDAC Inhibitors: Role in Cancer Therapeutics.

Tasneem S, Alam MM, Amir M, Akhter M, Parvez S, Verma G, Nainwal LM, Equbal A, Anwer T, Shaquiquzzaman M. Tasneem S, et al. Mini Rev Med Chem. 2022;22(12):1648-1706. doi: 10.2174/1389557519666211221144013. Mini Rev Med Chem. 2022. PMID: 34939540 Review.

7

Update on platelet procoagulant mechanisms in health and in bleeding disorders.

Bourguignon A, Tasneem S, Hayward CPM. Bourguignon A, et al. Among authors: tasneem s. Int J Lab Hematol. 2022 Sep;44 Suppl 1:89-100. doi: 10.1111/ijlh.13866. Int J Lab Hematol. 2022. PMID: 36074709 Review.

8

Advancement of Natural Compounds as Anti-rheumatoid Arthritis Agents: A Focus on Their Mechanism of Actions.

Yu H, Qiu Y, Tasneem S, Daniyal M, Li B, Cai X, Atta-Ur Rahman, Wang W. Yu H, et al. Among authors: tasneem s. Mini Rev Med Chem. 2021;21(19):2957-2975. doi: 10.2174/1389557521666210304112916. Mini Rev Med Chem. 2021. PMID: 33663365 Review.

9

Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives.

Sivanesan I, Tasneem S, Hasan N, Shin J, Muthu M, Gopal J, Oh JW. Sivanesan I, et al. Among authors: tasneem s. Polymers (Basel). 2022 May 24;14(11):2131. doi: 10.3390/polym14112131. Polymers (Basel). 2022. PMID: 35683804 Free PMC article. Review.

10

Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents.

Shaquiquzzaman M, Verma G, Marella A, Akhter M, Akhtar W, Khan MF, Tasneem S, Alam MM. Shaquiquzzaman M, et al. Among authors: tasneem s. Eur J Med Chem. 2015 Sep 18;102:487-529. doi: 10.1016/j.ejmech.2015.07.026. Epub 2015 Jul 18. Eur J Med Chem. 2015. PMID: 26310894 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year